Cargando…

Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease

Detalles Bibliográficos
Autor principal:	Noh, Junghyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for the Study of Obesity 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118008/ https://www.ncbi.nlm.nih.gov/pubmed/32182638 http://dx.doi.org/10.7570/jomes20017

Ejemplares similares

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis
por: Wijarnpreecha, Karn, et al.
Publicado: (2018)

Interaction between sarcopenia and nonalcoholic fatty liver disease
por: Joo, Sae Kyung, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2020)

Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease
por: Chung, Goh Eun, et al.
Publicado: (2019)

Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
por: Martínez-Beamonte, Roberto, et al.
Publicado: (2020)

Implications of comorbidities in nonalcoholic fatty liver disease
por: Song, Sherlot Juan, et al.
Publicado: (2023)

Risk factors in nonalcoholic fatty liver disease
por: Ko, Eunji, et al.
Publicado: (2023)

Imaging methods in the assessment of nonalcoholic fatty liver disease
por: Parente, Daniella Braz
Publicado: (2020)

Nonalcoholic Fatty Liver Disease: Its Mechanisms and Complications
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2013)

Noninvasive Markers for the Diagnosis of Nonalcoholic Fatty Liver Disease
por: Kim, Sang Yong
Publicado: (2013)

The utility of ezetimibe therapy in nonalcoholic fatty liver disease
por: Jun, Baek Gyu, et al.
Publicado: (2019)

Role of cenicriviroc in the management of nonalcoholic fatty liver disease
por: Neokosmidis, Georgios, et al.
Publicado: (2018)

Treating Nonalcoholic Fatty Liver Disease From the Outside In?
por: Flynn, Charles R.
Publicado: (2019)

Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
por: Alam, Shahinul, et al.
Publicado: (2021)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
por: Park, Ji-Won, et al.
Publicado: (2023)

Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?
por: Jang, Heejoon, et al.
Publicado: (2023)

Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
por: Ren, Tian-Yi, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease – a growing public health problem
por: Mikolašević, Ivana, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease
por: Makri, Evangelia, et al.
Publicado: (2016)

The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease
por: Idilman, Ilkay S., et al.
Publicado: (2023)

Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis
por: Kang, Seong Hee, et al.
Publicado: (2023)

Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories
por: Kantartzis, Konstantinos, et al.
Publicado: (2023)

Aerobic and Resistance Exercise: Synergistic Influence for Nonalcoholic Fatty Liver Disease
por: Chun, Ho Soo
Publicado: (2023)

Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease
por: Chung, Goh Eun, et al.
Publicado: (2023)

A crystal ball to forecast treatment responsiveness in nonalcoholic fatty liver disease
por: Hwang, Seonghwan, et al.
Publicado: (2022)

Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
por: Huh, Youn, et al.
Publicado: (2022)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Pratap, Abhijit, et al.
Publicado: (2023)

Risk factors of nonalcoholic fatty liver disease in healthy women
por: Guan, Hui, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease-based risk prediction of adverse pregnancy outcomes: Ready for prime time?
por: Lee, Seung Mi, et al.
Publicado: (2022)

Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
por: Jang, Byoung Kuk
Publicado: (2012)

Nonalcoholic fatty liver disease: One more reason to strengthen public health
por: Alaama, Tareef
Publicado: (2018)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Hepatic inflammation: an important target for biomarker development in nonalcoholic fatty liver disease
por: Khan, Hiba, et al.
Publicado: (2023)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

Synergistic Preventive Effect of Aerobic and Resistance Exercises on Nonalcoholic Fatty Liver Disease
por: Cho, Ju-Yeon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jf9q3ktqt3knmh117raudka56e